We are live on ! Find out more
T. Rowe Price Associates

T. Rowe Price Associates Portfolio holdings

AUM $865B
1-Year Est. Return 30.76%
 

T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.

This Fund
S&P 500
This Quarter Est. Return
+14.71%
1 Year Est. Return
+30.76%
3 Year Est. Return
+117.39%
5 Year Est. Return
+143.85%
10 Year Est. Return
+1,089.89%
AUM
$816B
AUM Growth
+$71.6B
Cap. Flow
-$12.2B
Cap. Flow %
-1.5%
Top 10 Hldgs %
32.14%
Holding
3,021
New
108
Increased
1,941
Reduced
738
Closed
64

Top Buys

Rank Stock Value
1
FTNT icon
Fortinet
FTNT
+$2.03B
2
ROK icon
Rockwell Automation
ROK
+$1.44B
3
ADSK icon
Autodesk
ADSK
+$1.15B
4
C icon
Citigroup
C
+$975M
5
COP icon
ConocoPhillips
COP
+$967M

Sector Composition

Rank Sector Weight
1 Technology 32.21%
2 Healthcare 15.42%
3 Financials 10.99%
4 Consumer Discretionary 10.39%
5 Communication Services 8.82%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
STRL icon
1351
Sterling Infrastructure
STRL
$16.8B
$3.25M ﹤0.01%
29,456
-3,503
-11% -$318K
DBX icon
1352
Dropbox
DBX
$7.31B
$3.25M ﹤0.01%
133,675
-58,342
-30% -$1.63M
GATX icon
1353
GATX Corp
GATX
$6.34B
$3.23M ﹤0.01%
24,125
+1,328
+6% +$167K
MDC
1354
DELISTED
M.D.C. Holdings, Inc.
MDC
$3.21M ﹤0.01%
51,013
+2,210
+5% +$135K
HBM icon
1355
Hudbay
HBM
$11.8B
$3.21M ﹤0.01%
458,347
+50,126
+12% +$292K
KTOS icon
1356
Kratos Defense & Security Solutions
KTOS
$11.8B
$3.21M ﹤0.01%
174,441
-10,594
-6% -$193K
MMS icon
1357
Maximus
MMS
$2.94B
$3.2M ﹤0.01%
38,100
+2,322
+6% +$191K
LITE icon
1358
Lumentum
LITE
$78B
$3.17M ﹤0.01%
66,874
-1,282
-2% -$65.2K
TSHA icon
1359
Taysha Gene Therapies
TSHA
$1.92B
$3.16M ﹤0.01%
1,099,329
-128,004
-10% -$267K
PII icon
1360
Polaris
PII
$3.9B
$3.15M ﹤0.01%
31,452
+929
+3% +$85.3K
RXST icon
1361
RxSight
RXST
$294M
$3.14M ﹤0.01%
60,908
+994
+2% +$48.8K
VEA icon
1362
Vanguard FTSE Developed Markets ETF
VEA
$239B
$3.14M ﹤0.01%
62,661
-22,684
-27% -$1.1M
CHKP icon
1363
Check Point Software Technologies
CHKP
$13.2B
$3.14M ﹤0.01%
19,139
+3,008
+19% +$482K
IJH icon
1364
iShares Core S&P Mid-Cap ETF
IJH
$128B
$3.13M ﹤0.01%
51,550
+28,485
+123% +$1.61M
CADE
1365
DELISTED
Cadence Bank
CADE
$3.12M ﹤0.01%
107,432
-3,670
-3% -$102K
TPH
1366
DELISTED
Tri Pointe Homes
TPH
$3.09M ﹤0.01%
79,976
+3,384
+4% +$119K
MATX icon
1367
Matsons
MATX
$6.41B
$3.06M ﹤0.01%
27,204
+1,214
+5% +$137K
ADC icon
1368
Agree Realty
ADC
$9.25B
$3.03M ﹤0.01%
53,028
+3,080
+6% +$180K
TFII icon
1369
TFI International
TFII
$12B
$3.02M ﹤0.01%
18,969
+11,444
+152% +$1.64M
TGI
1370
DELISTED
Triumph Group
TGI
$3.01M ﹤0.01%
200,167
-78,020
-28% -$1.16M
OBIO icon
1371
Orchestra BioMed
OBIO
$266M
$3.01M ﹤0.01%
571,075
-51,533
-8% -$349K
SEE
1372
DELISTED
Sealed Air
SEE
$3.01M ﹤0.01%
80,843
+4,471
+6% +$160K
ONB icon
1373
Old National Bancorp
ONB
$10.4B
$3.01M ﹤0.01%
172,646
+10,990
+7% +$182K
G icon
1374
Genpact
G
$5.7B
$3M ﹤0.01%
91,157
+5,496
+6% +$191K
LBTYK icon
1375
Liberty Global Class C
LBTYK
$3.46B
$3M ﹤0.01%
170,286
-2,544
-1% -$48.9K

Similar funds

T. Rowe Price Associates's Q1 2024 Portfolio in Review

As of Q1 2024, T. Rowe Price Associates held 3,021 positions worth $816B, up 9.6% from $744B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

T. Rowe Price Associates's Q1 2024 filing shows 108 new, 1,941 increased, 738 reduced and 64 closed positions. Its largest new stake was GE Vernova: 2,687,194 shares worth $367M. The largest sale was NVIDIA, an estimated $2.59B.

By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 31% a quarter earlier, followed by Healthcare and Financials.

  • T. Rowe Price Associates's largest Q1 2024 buy was GE Vernova: 2,687,194 shares worth $367M.
  • T. Rowe Price Associates added most to Fortinet in Q1 2024, an estimated $2.03B increase.
  • T. Rowe Price Associates's biggest Q1 2024 reduction was NVIDIA, cutting an estimated $2.59B.
  • T. Rowe Price Associates fully exited Karuna Therapeutics, Inc. Common Stock in Q1 2024, selling an estimated $621M.
  • T. Rowe Price Associates's ten largest holdings make up 32% of its $816B portfolio in Q1 2024.
  • T. Rowe Price Associates opened 108 new positions and closed 64 in Q1 2024.
  • T. Rowe Price Associates's portfolio value rose 9.6% quarter-over-quarter to $816B.

Based on T. Rowe Price Associates's 13F filing for Q1 2024, filed 15 May 2024.